SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-09-088175
Filing Date
2009-04-27
Accepted
2009-04-27 13:22:37
Documents
1
Period of Report
2009-06-10
Effectiveness Date
2009-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A ddef14a.htm DEF 14A 818721
  Complete submission text file 0001193125-09-088175.txt   820170
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-29089 | Film No.: 09771983
SIC: 2836 Biological Products, (No Diagnostic Substances)